GC
AVNS

Guggenheim Capital’s Avanos Medical AVNS Stock Holding History

Guggenheim Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,550
Closed -$384K – 2129
2021
Q2 		$384K Sell
10,550
-15,673
-60% -$648K ﹤0.01% 1925
2021
Q1 		$1.15M Sell
26,223
-4,295
-14% -$202K 0.01% 1324
2020
Q4 		$1.4M Buy
+30,518
New +$1.27M 0.01% 1159
2020
Q1 		– Sell
-7,783
Closed -$262K – 1849
2019
Q4 		$262K Sell
7,783
-14,020
-64% -$508K ﹤0.01% 1891
2019
Q3 		$817K Sell
21,803
-4,281
-16% -$163K 0.01% 1405
2019
Q2 		$1.14M Sell
26,084
-3,158
-11% -$135K 0.01% 1294
2019
Q1 		$1.25M Sell
29,242
-1,910
-6% -$85.5K 0.01% 1283
2018
Q4 		$1.4M Buy
+31,152
New +$1.63M 0.01% 1219
2018
Q2 		– Sell
-44,379
Closed -$2.05M – 2377
2018
Q1 		$2.05M Buy
44,379
+1,331
+3% +$63.2K 0.01% 1619
2017
Q4 		$1.99M Sell
43,048
-24,666
-36% -$1.13M ﹤0.01% 1672
2017
Q3 		$3.05M Sell
67,714
-3,473
-5% -$148K 0.01% 1370
2017
Q2 		$2.8M Sell
71,187
-2,460
-3% -$93K 0.01% 1379
2017
Q1 		$2.81M Sell
73,647
-6,392
-8% -$249K 0.01% 1400
2016
Q4 		$2.96M Buy
80,039
+38,127
+91% +$1.36M 0.01% 1380
2016
Q3 		$1.45M Sell
41,912
-4,448
-10% -$156K ﹤0.01% 1832
2016
Q2 		$1.51M Sell
46,360
-148,556
-76% -$4.55M ﹤0.01% 1755
2016
Q1 		$5.6M Sell
194,916
-38,221
-16% -$1.02M 0.02% 931
2015
Q4 		$7.79M Sell
233,137
-54,168
-19% -$1.68M 0.02% 843
2015
Q3 		$8.17M Sell
287,305
-64,808
-18% -$2.26M 0.03% 828
2015
Q2 		$14.3M Buy
352,113
+283,814
+416% +$12.7M 0.04% 705
2015
Q1 		$3.36M Buy
68,299
+1,825
+3% +$84.5K 0.01% 1394
2014
Q4 		$3.02M Buy
+66,474
New +$2.61M 0.01% 1430

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Guggenheim Capital's AVNS Position: Q3 2021 in Review

Guggenheim Capital sold out of Avanos Medical (AVNS) in Q3 2021, closing a stake of 10,550 shares — an estimated $384K sold.

Guggenheim Capital first reported a position in AVNS in Q4 2014 and held it in 22 quarters. The position peaked at $14.3M in Q2 2015. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2021.

  • Guggenheim Capital reported no remaining Avanos Medical position as of Q3 2021 after selling out during the quarter.
  • Guggenheim Capital sold 10,550 Avanos Medical shares in Q3 2021, an estimated $384K.
  • Guggenheim Capital first reported a position in Avanos Medical in Q4 2014 and held it in 22 quarters.
  • Guggenheim Capital's Avanos Medical position peaked at $14.3M in Q2 2015.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2021.

Based on Guggenheim Capital's 13F filing for Q3 2021, filed 15 Nov 2021.